These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 2849045

  • 41. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C.
    Parker SL, Parker MS, Sweatman T, Crowley WR.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):382-91. PubMed ID: 9655883
    [Abstract] [Full Text] [Related]

  • 42. Characterization of [125I][Ser1]histogranin binding sites in rat brain.
    Rogers C, Lemaire S.
    J Pharmacol Exp Ther; 1993 Oct; 267(1):350-6. PubMed ID: 8229761
    [Abstract] [Full Text] [Related]

  • 43. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB.
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [Abstract] [Full Text] [Related]

  • 44. Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells.
    Lobaugh LA, Blackshear PJ.
    Am J Physiol; 1990 May; 258(5 Pt 1):C913-22. PubMed ID: 2159234
    [Abstract] [Full Text] [Related]

  • 45. Neuropeptide Y receptor in bovine hippocampus is a Y2 receptor.
    Li W, MacDonald RG, Hexum TD.
    Life Sci; 1992 May; 50(10):695-703. PubMed ID: 1310789
    [Abstract] [Full Text] [Related]

  • 46. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A, Kanno T, Ishihara A, Hata M, Sakuraba A, Tanaka T, Tsuchiya Y, Mase T, Fukuroda T, Fukami T, Ihara M.
    Biochem Biophys Res Commun; 1999 Dec 09; 266(1):88-91. PubMed ID: 10581170
    [Abstract] [Full Text] [Related]

  • 47. Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist.
    Hegde SS, Bonhaus DW, Stanley W, Eglen RM, Moy TM, Loeb M, Shetty SG, DeSouza A, Krstenansky J.
    J Pharmacol Exp Ther; 1995 Dec 09; 275(3):1261-6. PubMed ID: 8531090
    [Abstract] [Full Text] [Related]

  • 48. Determination of guanine nucleotide sensitivity of [125-I]-neuropeptide Y binding in the rat pituitary gland by quantitative autoradiography.
    Torda T, Saavedra JM.
    Neuroendocrinology; 1990 Oct 09; 52(4):361-7. PubMed ID: 2175850
    [Abstract] [Full Text] [Related]

  • 49. Evidence for further heterogeneity of the receptors for neuropeptide-Y and peptide-YY in tumor cell lines derived from neural crest.
    Inui A, Sano K, Miura M, Hirosue Y, Nakajima M, Okita M, Baba S, Kasuga M.
    Endocrinology; 1992 Nov 09; 131(5):2090-6. PubMed ID: 1330489
    [Abstract] [Full Text] [Related]

  • 50. Neuropeptide Y (NPY) binding sites in rat brain labeled with 125I-Bolton-Hunter NPY: comparative potencies of various polypeptides on brain NPY binding and biological responses in the rat vas deferens.
    Chang RS, Lotti VJ, Chen TB, Cerino DJ, Kling PJ.
    Life Sci; 1985 Dec 02; 37(22):2111-22. PubMed ID: 2999540
    [Abstract] [Full Text] [Related]

  • 51. Neuropeptide Y modulates neurotransmitter release and Ca2+ currents in rat sensory neurons.
    Walker MW, Ewald DA, Perney TM, Miller RJ.
    J Neurosci; 1988 Jul 02; 8(7):2438-46. PubMed ID: 2907913
    [Abstract] [Full Text] [Related]

  • 52. Autoradiographic localization of peptide YY and neuropeptide Y binding sites in the medulla oblongata.
    Leslie RA, McDonald TJ, Robertson HA.
    Peptides; 1988 Jul 02; 9(5):1071-6. PubMed ID: 2854244
    [Abstract] [Full Text] [Related]

  • 53. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
    Neve KA, Henningsen RA, Kinzie JM, De Paulis T, Schmidt DE, Kessler RM, Janowsky A.
    J Pharmacol Exp Ther; 1990 Mar 02; 252(3):1108-16. PubMed ID: 2138666
    [Abstract] [Full Text] [Related]

  • 54. Quantitative autoradiographic localization of neuropeptide Y receptors in the rat lower brainstem.
    Nakajima T, Yashima Y, Nakamura K.
    Brain Res; 1986 Aug 13; 380(1):144-50. PubMed ID: 3019463
    [Abstract] [Full Text] [Related]

  • 55. p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors.
    Baron BM, Siegel BW.
    Mol Pharmacol; 1990 Sep 13; 38(3):348-56. PubMed ID: 1976227
    [Abstract] [Full Text] [Related]

  • 56. Neuropeptide Y receptor in cultured vascular smooth muscle cells: ligand binding and increase in cytosolic free Ca2+.
    Mihara S, Shigeri Y, Fujimoto M.
    Biochem Int; 1990 Oct 13; 22(2):205-12. PubMed ID: 2090091
    [Abstract] [Full Text] [Related]

  • 57. Neuropeptide Y modulates the binding of a gonadotropin-releasing hormone (GnRH) analog to anterior pituitary GnRH receptor sites.
    Parker SL, Kalra SP, Crowley WR.
    Endocrinology; 1991 May 13; 128(5):2309-16. PubMed ID: 1850349
    [Abstract] [Full Text] [Related]

  • 58. Localization and characterization of neuropeptide Y/peptide YY receptors in the brain of the smooth dogfish (Mustelis canis).
    McVey DC, Rittschof D, Mannon PJ, Vigna SR.
    Regul Pept; 1996 Mar 22; 61(3):167-73. PubMed ID: 8701032
    [Abstract] [Full Text] [Related]

  • 59. Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines.
    Sheikh SP, O'Hare MM, Tortora O, Schwartz TW.
    J Biol Chem; 1989 Apr 25; 264(12):6648-54. PubMed ID: 2708330
    [Abstract] [Full Text] [Related]

  • 60. Localization of neuropeptide Y binding sites in the zona glomerulosa of the bovine adrenal gland.
    Torda T, Cruciani RA, Saavedra JM.
    Neuroendocrinology; 1988 Aug 25; 48(2):207-10. PubMed ID: 2851754
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.